Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic I
- This topic has 2 replies, 2 voices, and was last updated 9 years, 6 months ago by
.
Viewing 3 posts - 1 through 3 (of 3 total)
-
Posts
-
Lots indeed coming out Duke and lets hope of course that it leads somewhere very very positive!
Gavin
There is so much coming out so quickly from so many groups, who is sitting back and trying to pull it all together into a coherent picture? Or trying to combine study results to come up with more focused studies? Probably too big for one organization, but could be divided into ICC, ECC, and distal among Mayo, MDA, MSK, and others. Lots of opportunities for institutions in the UK and elsewhere.
Duke
Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications.
http://www.ncbi.nlm.nih.gov/pubmed/25536104
Viewing 3 posts - 1 through 3 (of 3 total)
- The forum ‘New Developments’ is closed to new topics and replies.